A cost-effectiveness model for coronary thrombolysis/reperfusion therapy
- 30 November 1987
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 10 (5) , 79B-90B
- https://doi.org/10.1016/s0735-1097(87)80432-1
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A Prospective Randomized Clinical Trial of Intracoronary Streptokinase versus Coronary Angioplasty for Acute Myocardial InfarctionNew England Journal of Medicine, 1986
- Identification and Treatment of Low-Risk Patients after Acute Myocardial Infarction and Coronary-Artery Bypass Graft SurgeryNew England Journal of Medicine, 1986
- Prevention of Myocardial Damage in Acute Myocardial Ischemia by Early Treatment with Intravenous StreptokinaseNew England Journal of Medicine, 1985
- In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty.Circulation, 1985
- The Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1985
- Effects of Intracoronary Streptokinase and Intracoronary Nitroglycerin Infusion on Coronary Angiographic Patterns and Mortality in Patients with Acute Myocardial InfarctionNew England Journal of Medicine, 1984
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions.Circulation, 1984
- Does Visual Interpretation of the Coronary Arteriogram Predict the Physiologic Importance of a Coronary Stenosis?New England Journal of Medicine, 1984
- Risk Stratification and Survival after Myocardial InfarctionNew England Journal of Medicine, 1983